Propane

Propane

SCHEMBL7213006

CCC.NCCc1ccc(NS(=O)(=O)c2ccc(F)cc2Cl)cc1

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CA7 P43166 1/20 0.49
CA9 Q16790 1/20 0.49
CA14 Q9ULX7 1/20 0.49
HTR6 P50406 1/20 0.48
FFAR1 O14842 1/20 0.47
FFAR4 Q5NUL3 1/20 0.47
BRD4 O60885 3/20 0.47
SGK1 O00141 7/20 0.46
ACLY P53396 1/20 0.45
TP53 P04637 1/20 0.44
PFKFB3 Q16875 1/20 0.43
PTGES2 Q9H7Z7 1/20 0.42
ALDH1A1 P00352 1/20 0.42
MAPT P10636 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
FABP4 P15090 1/20 0.41
FABP5 Q01469 1/20 0.41
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propane SCHEMBL7212983 0.88 TP53 (0.54) CA1CA2CA7CA9CA14
SCHEMBL7213002 0.87 ACLY (0.49) CA1CA2CA7CA9CA14
SCHEMBL7211646 0.83 FFAR1 (0.48) CA1CA2CA7CA9CA14
SCHEMBL13629290 0.79 BRD4 (0.52) HTR6BRD4SGK1PFKFB3ALDH1A1
SCHEMBL95834 0.76 BRD4 (0.51) CA1CA2CA7CA9CA14
SCHEMBL14018751 0.76 ALDH1A1 (0.63) CA1CA2BRD4SGK1ACLY
SCHEMBL13629339 0.75 BRD4 (0.51) HTR6BRD4SGK1TP53PFKFB3
SCHEMBL7212979 0.74 ACLY (0.57) CA1CA2CA7CA9CA14
Propane SCHEMBL7208109 0.74 HTR6 (0.67) HTR6FFAR1FFAR4ALDH1A1HTT
SCHEMBL13615216 0.73 BRD4 (0.52) HTR6BRD4SGK1PFKFB3FABP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1077935-B1 PHENYLSULFONAMIDE-PHENYLETHYLAMINES USEFUL AS DOPAMINE RECEPTORS UPJOHN CO (US) 2003-10-29 EP claimed
EP-1077935-A1 PHENYLSULFONAMIDE-PHENYLETHYLAMINES USEFUL AS DOPAMINE RECEPTORS PHARMACIA & UPJOHN COMPANY (US) 2001-02-28 EP claimed
US-6103766-A SUBSTITUTED OR UNSUBSTITUTED PHENYLSULFONAMIDE-PHENYLAMINE DERIVATIVES USEFUL FOR TREATING THE DISORDERS RELATED TO CENTRAL NERVOUS SYSTEM PHARMACIA & UPJOHN COMPANY (US) 2000-08-15 US claimed
WO-1999058499-A1 PHENYLSULFONAMIDE-PHENYLETHYLAMINES USEFUL AS DOPAMINE RECEPTORS PHARMACIA & UPJOHN COMPANY (US) 1999-11-18 WO claimed
EP-1077935-B1 PHENYLSULFONAMIDE-PHENYLETHYLAMINES USEFUL AS DOPAMINE RECEPTORS UPJOHN CO (US) 2003-10-29 EP disclosed
EP-1077935-A1 PHENYLSULFONAMIDE-PHENYLETHYLAMINES USEFUL AS DOPAMINE RECEPTORS PHARMACIA & UPJOHN COMPANY (US) 2001-02-28 EP disclosed
US-6103766-A SUBSTITUTED OR UNSUBSTITUTED PHENYLSULFONAMIDE-PHENYLAMINE DERIVATIVES USEFUL FOR TREATING THE DISORDERS RELATED TO CENTRAL NERVOUS SYSTEM PHARMACIA & UPJOHN COMPANY (US) 2000-08-15 US disclosed
WO-1999058499-A1 PHENYLSULFONAMIDE-PHENYLETHYLAMINES USEFUL AS DOPAMINE RECEPTORS PHARMACIA & UPJOHN COMPANY (US) 1999-11-18 WO disclosed